Table 1.

Demographics of the study subjects for evaluation of peripheral blood

Group	No. of patients	Age (years) median	F	M
Healthy controls	10	31 (21–55)	4	6
Patients with PASI <5	11	41 (21–48)	4	7
Patients with PASI >20	11	46 (18–75)	3	8

Abbreviation: PASI, Psoriasis Area Severity Index.